Yüklüyor......
Randomised clinical trial: a dose‐ranging study of vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis
BACKGROUND: The potassium‐competitive acid blocker vonoprazan (VPZ) has potent acid‐inhibitory effects and may offer clinical advantages over conventional therapy for acid‐related disorders. AIM: To investigate the efficacy and safety of VPZ in patients with erosive oesophagitis (EO). METHODS: In th...
Kaydedildi:
| Yayımlandı: | Aliment Pharmacol Ther |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5014135/ https://ncbi.nlm.nih.gov/pubmed/26201312 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.13331 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|